基于线性机器学习的预测模型可仅凭MGMT甲基化状态、年龄和性别估算胶质母细胞瘤患者的生存月数
本研究利用本脑肿瘤中心218例胶质母细胞瘤患者的回顾性数据,在重复十折回归中比较五种线性和非线性回归器的预测性能,以年龄、性别和MGMT甲基化状态预测个体生存月数。最佳机器学习算法的平均绝对误差为12.65(SD=±2.18),解释方差为7%(SD=±1.8%),P<0.001;线性算法预测比非线性算法更准确,特征重要性测试显示年龄和MGMT甲基化阳性对预测影响最大。作者认为该新方法可仅基于年龄、性别和MGMT甲基化状态预测胶质母细胞瘤患者的生存月数,并强调MGMT甲基化状态是胶质母细胞瘤患者生存的关键预后因素。
要点
- 基于218例胶质母细胞瘤患者回顾性数据构建预测生存月数的机器学习模型。
- 最佳算法平均绝对误差12.65(SD=±2.18),解释方差7%(SD=±1.8%),P<0.001。
- 线性算法预测比非线性算法更准确,年龄和MGMT甲基化阳性对预测影响最大。
核心结论
- 作者提供了一种仅基于年龄、性别和MGMT甲基化状态预测胶质母细胞瘤患者生存月数的新方法,并强调MGMT甲基化状态是胶质母细胞瘤患者生存的关键预后因素。
研究设计与样本
- 利用本脑肿瘤中心218例患者的回顾性数据,在重复十折回归中评估机器学习模型性能,流程包含五种回归估计器(含线性与非线性算法),采用置换特征重要性及置换检验评估统计显著性。
主要发现
- 最佳机器学习算法的平均绝对误差为12.65(SD=±2.18),解释方差为7%(SD=±1.8%),P<0.001。
- 线性算法较非线性估计器产生更准确的预测。
- 特征重要性测试表明年龄和MGMT甲基化阳性对预测的影响最大。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Machine Learning (ML) has become an essential tool for analyzing biomedical data, facilitating the prediction of treatment outcomes and patient survival. However, the effectiveness of ML models heavily relies on both the choice of algorithms and the quality of the input data. In this study, we aimed to develop a novel predictive model to estimate individual survival for patients diagnosed with glioblastoma (GBM), focusing on key variables such as O6-Methylguanine-DNA Methyltransferase (MGMT) methylation status, age, and sex. METHODS: To identify the optimal approach, we utilized retrospective data from 218 patients treated at our brain tumor center. The performance of the ML models was evaluated within repeated tenfold regression. The pipeline comprised five regression estimators, including both linear and non-linear algorithms. Permutation feature importance highlighted the feature with the most significant impact on the model. Statistical significance was assessed using a permutation test procedure. RESULTS: The best machine learning algorithm achieved a mean absolute error (MAE) of 12.65 (SD = ± 2.18) and an explained variance (EV) of 7% (SD = ± 1.8%) with p < 0.001. Linear algorithms led to more accurate predictions than non-linear estimators. Feature importance testing indicated that age and positive MGMT-methylation influenced the predictions the most. CONCLUSION: In summary, here we provide a novel approach allowing to predict GBM patient's survival in months solely based on key parameters such as age, sex and MGMT-methylation status and underscores MGMT-methylation status as key prognostic factor for GBM patients survival.
引用
- Maragno E, Ricchizzi S, Winter NR, et al. Predictive modeling with linear machine learning can estimate glioblastoma survival in months based solely on MGMT-methylation status, age and sex. Acta Neurochir (Wien). 2025. PMID: 39992425. doi:10.1007/s00701-025-06441-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。